Cite
APA Citation
Oza, A. M., Cibula, D., Benzaquen, A. O., Poole, C., Mathijssen, R. H. J., Sonke, G. S., Colombo, N., Špaček, J., Vuylsteke, P., Hirte, H., Mahner, S., Plante, M., Schmalfeldt, B., Mackay, H., Rowbottom, J., Lowe, E. S., Dougherty, B., Barrett, J. C., & Friedlander, M. (n.d.). olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial. Lancet oncology, 16(1), 87–97. http://access.bl.uk/ark:/81055/vdc_100025859523.0x000002